Aneuploidy Enables Cross-Adaptation to Unrelated Drugs
Open accessThe DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
Aneuploidy is common both in tumor cells responding to chemotherapeutic agents and in fungal cells adapting to antifungal drugs. Because aneuploidy simultaneously affects many genes, it has the potential to confer multiple phenotypes to the same cells. Here, we analyzed the mechanisms by which Candida albicans, the most prevalent human fungal pathogen, acquires the ability to survive both chemotherapeutic agents and antifungal drugs. Strikingly, adaptation to both types of drugs was accompanied by the acquisition of specific whole-chromosome aneuploidies, with some aneuploid karyotypes recovered independently and repeatedly from very different drug conditions. Specifically, strains selected for survival in hydroxyurea, an anticancer drug, acquired cross-adaptation to caspofungin, a first-line antifungal drug, and both acquired traits were attributable to trisomy of the same chromosome: loss of trisomy was accompanied by loss of adaptation to both drugs. Mechanistically, aneuploidy simultaneously altered the copy number of most genes on chromosome 2, yet survival in hydroxyurea or caspofungin required different genes and stress response pathways. Similarly, chromosome 5 monosomy conferred increased tolerance to both fluconazole and to caspofungin, antifungals with different mechanisms of action. Thus, the potential for cross-adaptation is not a feature of aneuploidy per se; rather, it is dependent on specific genes harbored on given aneuploid chromosomes. Furthermore, pre-exposure to hydroxyurea increased the frequency of appearance of caspofungin survivors, and hydroxyurea-adapted C. albicans cells were refractory to antifungal drug treatment in a mouse model of systemic candidiasis. This highlights the potential clinical consequences for the management of cancer chemotherapy patients at risk of fungal infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Fig. 7. Effect of HU pre-exposure on cross-adaptation to caspofungin. Parental strain SC5314 was passaged daily for 7 days in YPD+HU (IC50; 2.814 mg/ml) at 37 °C, washed, and growth was measured on either solid (A) or liquid (B) medium. (A) ∼1 × 105 cells were plated on YPD plates (with or without CSP [100 ng/ml] as indicated) and incubated at 37 °C for 3 days. (B) Passaged cells (with or without HU from the pre-exposure period above) were plated on YPD at a cell density of ∼200 CFUs/plate and incubated at 37 °C for 24 h. From each plate, 94 colonies from the control YPD treatment (gray curves), and 94 colonies from the YPD+HU treatment (blue curves) were randomly selected and grown at 37 °C in YPD with or without CSP (100 ng/ml); parental strain without pre-exposure was also tested (red curves). Growth was measured as absorbance at 600 nm every 15 min. (C) Strains evolved for 7 days as above were analyzed by spot assays. Serial dilutions of cell suspension were spotted (3 µl/spot) on YPD plates supplemented with the indicated concentrations of HU or CSP and incubated at 37 °C for 48 h. Each condition was tested a minimum of three independent times. Growth is represented in a heat map comparing strains with or without Chr2 trisomy (Chr2x3, euploid, respectively), as described in methods.](https://figures.cochat.ai/paper-figures/33dd5a021e3e44cabf27e77683ac988e/aneuploidy-enables-cross-adaptation-to-unrelated-drugs-figure-7.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent work in C. albicans demonstrated that exposure to the cancer chemotherapeutic hydroxyurea, or the ER stress-inducing agent tunicamycin selects for trisomy of chromosome 2, which also enables tolerance to the echinocandin caspofungin66,67.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [66]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Yang et al. found three negative regulators of echinocandin susceptibility on chr5. These are CHT2, encoding a glycosylphosphatidylinositol (GPI)-dependent chitinase, a covalently bound cell wall protein, PGA4, encoding a GPI-anchored cell surface 1,3-β-d-glucanosyltransferase, and CSU51 encoding another putative GPI-anchored protein [132].”
From Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance (2025) · cites this paper as [132]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Copy number variations, including whole-chromosome aneuploidy and shorter-range amplifications, are genome changes that can increase resistance32,43–49.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [48]
The cited source says what the claim attributes to it.
In the citing paper
“C. albicans’ heteroresistance to echinocandins is related to chr2, as chr2 trisomy can be induced after exposure to caspofungin [132].”
From Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance (2025) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · cited 1×
“The images were processed by a custom Fiji/ ImageJ plugin (Schindelin et al. 2012; Schneider et al. 2012).”
MethodNIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638 · cited 1×
“The images were processed by a custom Fiji/ ImageJ plugin (Schindelin et al. 2012; Schneider et al. 2012).”
MethodHidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284 · cited 1×
“A leading cause of such infections is Candida albicans, a common member of the commensal microbiome (Brown et al. 2012; Mousset et al. 2014; Lai et al. 2019).”
BackgroundPappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Isogenic strain construction and gene mapping in Candida albicans.
Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,687
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298 · cited 1×
“This also implies that cancer chemotherapy with HU has the potential to promote cross-adaptation to CSP. Relevance In Vivo CSP is a first-line antifungal drug used in clinics for the treatment of systemic candidiasis (Pappas et al. 2016).”
BackgroundGenome evolution across 1,011 Saccharomyces cerevisiae isolates
Peter, J., De Chiara, M., Friedrich, A., Yue, J.-X., Pflieger, D., Bergström, A., Sigwalt, A., Barre, B., Freel, K., Llored, A., et al. (2018) · Nature · doi:10.1038/s41586-018-0030-5 · Cited by 1,117 · cited 1×
“albicans: wild and clinical isolates of the model yeast Saccharomyces cerevisiae often carry aneuploidies as well (Sunshine et al. 2015; Gallone et al. 2016; Gasch et al. 2016; Zhu et al. 2016; Peter et al. 2018).”
BackgroundEffects of Aneuploidy on Cellular Physiology and Cell Division in Haploid Yeast
Torres, E. M., Sokolsky, T., Tucker, C. M., Chan, L. Y., Boselli, M., Dunham, M. J., & Amon, A. (2007) · Science · doi:10.1126/science.1142210 · Cited by 935 · cited 1×
“Aneuploidies often incur a fitness cost, reducing adaptation to many growth conditions (Torres et al. 2007; Sheltzer and Amon 2011).”
BackgroundAneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2006) · Science · doi:10.1126/science.1128242 · Cited by 733
Self-citationHsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698 · cited 1×
“Eukaryotic cells adapt to a broad range of stresses, with a classic example being the rapid adaptation of yeast cells to antifungal therapies (Cowen and Lindquist 2005; Bennett et al. 2014; Berman 2016).”
BackgroundDomestication and Divergence of Saccharomyces cerevisiae Beer Yeasts
Gallone, B., Steensels, J., Prahl, T., Soriaga, L., Saels, V., Herrera-Malaver, B., Merlevede, A., Roncoroni, M., Voordeckers, K., Miraglia, L., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.020 · Cited by 679
Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast
Pavelka, N., Rancati, G., Zhu, J., Bradford, W. D., Saraf, A., Florens, L., Sanderson, B. W., Hattem, G. L., & Li, R. (2010) · Nature · doi:10.1038/nature09529 · Cited by 577
Self-citationFluconazole resistance in Candida species: a current perspective
Berkow, E., & Lockhart, S. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s118892 · Cited by 542
Resistance to echinocandin-class antifungal drugs.
Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512
Campoy, S., & Adrio, J. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.019 · Cited by 511
Widespread aneuploidy revealed by DNA microarray expression profiling
Hughes, T. R., Roberts, C. J., Dai, H., Jones, A. R., Meyer, M. R., Slade, D., Burchard, J., Dow, S., Ward, T. R., Kidd, M. J., et al. (2000) · Nature Genetics · doi:10.1038/77116 · Cited by 482 · cited 1×
“2015), and are common mechanisms of suppressing the deleterious effects of specific deletion mutations (Hughes et al. 2000; Rancati et al. 2008; Liu et al. 2015).”
BackgroundStimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins
Walker, L. A., Munro, C. A., de Bruijn, I., Lenardon, M. D., McKinnon, A., & Gow, N. A. R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000040 · Cited by 445
Park, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434
Precise estimates of mutation rate and spectrum in yeast
Zhu, Y. O., Siegal, M. L., Hall, D. W., & Petrov, D. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323011111 · Cited by 420 · cited 1×
“Is the drug merely selecting on standing karyotypic variation or inducing aneuploidy de novo? Mitotic errors leading to aneuploidy occur relatively frequently in fungi, even under optimal laboratory conditions (Zhu et al. 2014), leading to a large variety of karyotypes in both natural and clinical isolates (Hirakawa e…”
BackgroundChromosomal duplication is a transient evolutionary solution to stress
Yona, A. H., Manor, Y. S., Herbst, R. H., Romano, G. H., Mitchell, A., Kupiec, M., Pilpel, Y., & Dahan, O. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211150109 · Cited by 376 · cited 2×
“Furthermore, the acquisition of aneuploidy may provide a transient, albeit unstable and imperfect, solution to a given stress condition that facilitates the acquisition of more beneficial and stable mutations in the long run (Yona et al. 2012).”
BackgroundGenome-wide genetic analysis of polyploidy in yeast
Storchová, Z., Breneman, A., Cande, J., Dunn, J., Burbank, K., O'Toole, E., & Pellman, D. (2006) · Nature · doi:10.1038/nature05178 · Cited by 366 · cited 1×
“Yet, large-scale genome changes, such as changes in chromosome number or structure, occur much more frequently and simultaneously affect larger numbers of genes, making them more likely to produce pleiotropic side effects (Storchova et al. 2006; Chen, Rubinstein, et al. 2012).”
BackgroundRancati, G., Pavelka, N., Fleharty, B., Noll, A., Trimble, R., Walton, K., Perera, A., Staehling-Hampton, K., Seidel, C. W., & Li, R. (2008) · Cell · doi:10.1016/j.cell.2008.09.039 · Cited by 344 · cited 3×
“Furthermore, whole chromosome and segmental aneuploidies are often detected during in vitro evolution (Adams et al. 1992; Perepnikhatka et al. 1999; Koszul et al. 2004; Rancati et al. 2008; Gresham et al. 2010; Liu et al. 2015), and are common mechanisms of suppressing the deleterious effects of specific deletion muta…”
BackgroundSelf-citationDouglas, C. M., D'Ippolito, J. A., Shei, G. J., Meinz, M., Onishi, J., Marrinan, J. A., Li, W., Abruzzo, G. K., Flattery, A., Bartizal, K., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2471 · Cited by 344 · cited 2×
“GSC1 encodes the essential b-1, 3-glucan synthase subunit, which is the target of CSP (Douglas et al. 1997), and is known to harbor specific substitutions in CSP-resistant C.”
BackgroundInfluentialAn isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1
Selmecki, A., Gerami‐Nejad, M., Paulson, C., Forche, A., & Berman, J. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06176.x · Cited by 325 · cited 1×
“In all cases where the molecular mechanism was determined, the adaptive value of a specific aneuploidy to a specific environment has been attributable to the altered copy number of one or more specific genes on the aneuploid chromosome (Rancati et al. 2008; Selmecki et al. 2008; Gresham et al. 2010; Pavelka, Rancati,…”
BackgroundSelf-citationGenetic and phenotypic intra-species variation in Candida albicans
Hirakawa, M. P., Martinez, D. A., Sakthikumar, S., Anderson, M. Z., Berlin, A., Gujja, S., Zeng, Q., Zisson, E., Wang, J. M., Greenberg, J. M., et al. (2015) · Genome Research · doi:10.1101/gr.174623.114 · Cited by 320 · cited 1×
“2014), leading to a large variety of karyotypes in both natural and clinical isolates (Hirakawa et al. 2015; Hose et al. 2015).”
BackgroundSelf-citationMechanisms of echinocandin antifungal drug resistance
Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313
Ferrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · cited 1×
“In fact, experimental evolution of bacteria or yeast under one environmental condition sometimes leads to the acquisition of selective advantages in a second, unselected condition (Ferrari et al. 2009; Roux et al. 2015; Hampe et al. 2017).”
BackgroundThe ‘obligate diploid’ Candida albicans forms mating-competent haploids
Hickman, M. A., Zeng, G., Forche, A., Hirakawa, M. P., Abbey, D., Harrison, B. D., Wang, Y.-M., Su, C.-H., Bennett, R. J., Wang, Y., et al. (2013) · Nature · doi:10.1038/nature11865 · Cited by 284 · cited 1×
“Whole-genome sequencing of representative Type 1 and Type 2 small and large isolates was analyzed using YMAP, which displays copy number and allelic frequency as a function of chromosomal position (Abbey et al. 2011; Hickman et al. 2013).”
MethodSelf-citationThe aneuploidy paradox: costs and benefits of an incorrect karyotype
Sheltzer, J. M., & Amon, A. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.07.003 · Cited by 277 · cited 1×
“Aneuploidies often incur a fitness cost, reducing adaptation to many growth conditions (Torres et al. 2007; Sheltzer and Amon 2011).”
BackgroundHsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy
Chen, G., Bradford, W. D., Seidel, C. W., & Li, R. (2012) · Nature · doi:10.1038/nature10795 · Cited by 274
Development of a Comprehensive Genotype-to-Fitness Map of Adaptation-Driving Mutations in Yeast
Venkataram, S., Dunn, B., Li, Y., Agarwala, A., Chang, J., Ebel, E. R., Geiler-Samerotte, K., Hérissant, L., Blundell, J. R., Levy, S. F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.002 · Cited by 271 · cited 1×
“The Calcineurin Pathway Does Not Contribute to Survival in HU The calcineurin pathway contributes to the ability of C. albicans to tolerate CSP (Walker et al. 2008).”
BackgroundMousset, S., Buchheidt, D., Heinz, W., Ruhnke, M., Cornely, O. A., Egerer, G., Krüger, W., Link, H., Neumann, S., Ostermann, H., et al. (2014) · Annals of Hematology · doi:10.1007/s00277-013-1867-1 · Cited by 255 · cited 1×
“A leading cause of such infections is Candida albicans, a common member of the commensal microbiome (Brown et al. 2012; Mousset et al. 2014; Lai et al. 2019).”
BackgroundA recyclableCandida albicans URA3 cassette for PCR product-directed gene disruptions
Wilson, R. B., Davis, D. A., Enloe, B. M., & Mitchell, A. P. (2000) · Yeast · doi:10.1002/(sici)1097-0061(20000115)16:1<65::aid-yea508>3.0.co;2-m · Cited by 250 · cited 1×
“albicans following the lithium acetate method (Wilson et al. 2000).”
Lázár, V., Nagy, I., Spohn, R., Csörgő, B., Györkei, Á., Nyerges, Á., Horváth, B., Vörös, A., Busa-Fekete, R., Hrtyan, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5352 · Cited by 249
Genomic Plasticity of the Human Fungal Pathogen Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2010) · Eukaryotic Cell · doi:10.1128/ec.00060-10 · Cited by 247 · cited 1×
“albicans, which does not undergo classical meiosis, has a high degree of genome plasticity and a high tolerance for aneuploidy (Rustchenko 2007; Selmecki et al. 2010).”
BackgroundSelf-citationStress Alters Rates and Types of Loss of Heterozygosity in Candida albicans
Forche, A., Abbey, D., Pisithkul, T., Weinzierl, M. A., Ringstrom, T., Bruck, D., Petersen, K., & Berman, J. (2011) · mBio · doi:10.1128/mbio.00129-11 · Cited by 234
Self-citationEucaryotic genome evolution through the spontaneous duplication of large chromosomal segments
Koszul, R., Caburet, S., Dujon, B., & Fischer, G. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600024 · Cited by 216 · cited 1×
“Furthermore, whole chromosome and segmental aneuploidies are often detected during in vitro evolution (Adams et al. 1992; Perepnikhatka et al. 1999; Koszul et al. 2004; Rancati et al. 2008; Gresham et al. 2010; Liu et al. 2015), and are common mechanisms of suppressing the deleterious effects of specific deletion muta…”
BackgroundSpeciation driven by hybridization and chromosomal plasticity in a wild yeast
Leducq, J.-B., Nielly-Thibault, L., Charron, G., Eberlein, C., Verta, J.-P., Samani, P., Sylvester, K., Hittinger, C. T., Bell, G., & Landry, C. R. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2015.3 · Cited by 181 · cited 1×
“2016), in environmental isolates (Hose et al. 2015; Leducq et al. 2016), in-”
The Genomic Landscape and Evolutionary Resolution of Antagonistic Pleiotropy in Yeast
Qian, W., Ma, D., Xiao, C., Wang, Z., & Zhang, J. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.017 · Cited by 179
A Tetraploid Intermediate Precedes Aneuploid Formation in Yeasts Exposed to Fluconazole
Harrison, B. D., Hashemi, J., Bibi, M., Pulver, R., Bavli, D., Nahmias, Y., Wellington, M., Sapiro, G., & Berman, J. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001815 · Cited by 174 · cited 2×
“aneuploid chromosomes (Harrison et al. 2014) or by strongly selecting for standing karyotypic variation (see Discussion).”
BackgroundSelf-citationFitness cost of antibiotic susceptibility during bacterial infection
Roux, D., Danilchanka, O., Guillard, T., Cattoir, V., Aschard, H., Fu, Y., Angoulvant, F., Messika, J., Ricard, J.-D., Mekalanos, J. J., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab1621 · Cited by 169 · cited 1×
“In fact, experimental evolution of bacteria or yeast under one environmental condition sometimes leads to the acquisition of selective advantages in a second, unselected condition (Ferrari et al. 2009; Roux et al. 2015; Hampe et al. 2017).”
BackgroundGene Essentiality Is a Quantitative Property Linked to Cellular Evolvability
Liu, G., Yong, M. Y. J., Yurieva, M., Srinivasan, K. G., Liu, J., Lim, J. S. Y., Poidinger, M., Wright, G. D., Zolezzi, F., Choi, H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.069 · Cited by 160 · cited 7×
“2015), and are common mechanisms of suppressing the deleterious effects of specific deletion mutations (Hughes et al. 2000; Rancati et al. 2008; Liu et al. 2015).”
BackgroundMethodInfluentialSelf-citationSelmecki, A., Bergmann, S., & Berman, J. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04492.x · Cited by 157
Self-citationShen, J., Guo, W., & Köhler, J. R. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.1239-1242.2005 · Cited by 155
Acquired resistance to echinocandins in Candida albicans: case report and review
Baixench, M.-T., Aoun, N., Desnos-Ollivier, M., Garcia-Hermoso, D., Bretagne, S., Ramires, S., Piketty, C., & Dannaoui, E. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm095 · Cited by 150 · cited 1×
“glabrata, and Candida krusei (Pelletier et al. 2005; Baixench et al. 2007; Lewis et al. 2013; Forastiero et al. 2015; Sasso et al. 2017), as well as in Candida auris, which is intrinsically FLC-resistant and has caused multidrug-resistant A ricle”
BackgroundAbbey, D. A., Funt, J., Lurie-Weinberger, M. N., Thompson, D. A., Regev, A., Myers, C. L., & Berman, J. (2014) · Genome Medicine · doi:10.1186/s13073-014-0100-8 · Cited by 147 · cited 3×
“YMAP analysis also confirmed that a HU survivor (YFT1), previously shown to carry increased DNA content (fig.”
MethodSelf-citationZhu, Y. O., Sherlock, G., & Petrov, D. A. (2016) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.116.029397 · Cited by 145 · cited 2×
“chromosomes or chromosomal segments, arises at relatively high frequency in eukaryotic cells (Lee et al. 2010; Sterkers et al. 2012; Gallone et al. 2016; Gasch et al. 2016; Zhu et al. 2016).”
BackgroundSpecific Chromosome Alterations in Fluconazole-Resistant Mutants of Candida albicans
Perepnikhatka, V., Fischer, F. J., Niimi, M., Baker, R. A., Cannon, R. D., Wang, Y.-K., Sherman, F., & Rustchenko, E. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.13.4041-4049.1999 · Cited by 141 · cited 1×
“Furthermore, whole chromosome and segmental aneuploidies are often detected during in vitro evolution (Adams et al. 1992; Perepnikhatka et al. 1999; Koszul et al. 2004; Rancati et al. 2008; Gresham et al. 2010; Liu et al. 2015), and are common mechanisms of suppressing the deleterious effects of specific deletion muta…”
BackgroundGresham, D., Usaite, R., Germann, S. M., Lisby, M., Botstein, D., & Regenberg, B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014023107 · Cited by 140 · cited 2×
“Furthermore, whole chromosome and segmental aneuploidies are often detected during in vitro evolution (Adams et al. 1992; Perepnikhatka et al. 1999; Koszul et al. 2004; Rancati et al. 2008; Gresham et al. 2010; Liu et al. 2015), and are common mechanisms of suppressing the deleterious effects of specific deletion muta…”
BackgroundNovel insights into genome plasticity in Eukaryotes: mosaic aneuploidy in Leishmania
Sterkers, Y., Lachaud, L., Bourgeois, N., Crobu, L., Bastien, P., & Pagès, M. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08185.x · Cited by 136 · cited 1×
“chromosomes or chromosomal segments, arises at relatively high frequency in eukaryotic cells (Lee et al. 2010; Sterkers et al. 2012; Gallone et al. 2016; Gasch et al. 2016; Zhu et al. 2016).”
BackgroundTargeting the Adaptability of Heterogeneous Aneuploids
Chen, G., Mulla, W. A., Kucharavy, A., Tsai, H.-J., Rubinstein, B., Conkright, J., McCroskey, S., Bradford, W. D., Weems, L., Haug, J. S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.026 · Cited by 134 · cited 1×
“the adaptation of the organism to another environment (Chen et al. 2015; Sunshine et al. 2015).”
BackgroundSelf-citationDosage compensation can buffer copy-number variation in wild yeast
Hose, J., Yong, C. M., Sardi, M., Wang, Z., Newton, M. A., & Gasch, A. P. (2015) · eLife · doi:10.7554/elife.05462 · Cited by 130 · cited 2×
“2014), leading to a large variety of karyotypes in both natural and clinical isolates (Hirakawa et al. 2015; Hose et al. 2015).”
BackgroundLow Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains
Castanheira, M., Woosley, L. N., Diekema, D. J., Messer, S. A., Jones, R. N., & Pfaller, M. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01711-09 · Cited by 125 · cited 1×
“Resistance to CSP is largely conferred by mutations within the “hot spot” regions of genes encoding beta-glucan synthase (Perlin 2015), however strains that do not carry these mutations and grow slowly in CSP are often isolated from patients (Castanheira et al. 2010; Shields et al. 2015).”
BackgroundAdaptation and major chromosomal changes in populations of Saccharomyces cerevisiae
Adams, J., Puskas-Rozsa, S., Simlar, J., & Wilke, C. M. (1992) · Current Genetics · doi:10.1007/bf00351736 · Cited by 123 · cited 1×
“Furthermore, whole chromosome and segmental aneuploidies are often detected during in vitro evolution (Adams et al. 1992; Perepnikhatka et al. 1999; Koszul et al. 2004; Rancati et al. 2008; Gresham et al. 2010; Liu et al. 2015), and are common mechanisms of suppressing the deleterious effects of specific deletion muta…”
BackgroundOnyewu, C., Wormley, F. L., Perfect, J. R., & Heitman, J. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.7330-7333.2004 · Cited by 121 · cited 1×
“scription factor involved in azole tolerance (Onyewu et al. 2004) but calcineurin-mediated CSP tolerance was shown to”
BackgroundDetecting selective sweeps in naturally occurring Escherichia coli.
Guttman, D. S., & Dykhuizen, D. E. (1994) · Genetics · doi:10.1093/genetics/138.4.993 · Cited by 121
Bennett, R. J., Forche, A., & Berman, J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019604 · Cited by 118 · cited 1×
“Eukaryotic cells adapt to a broad range of stresses, with a classic example being the rapid adaptation of yeast cells to antifungal therapies (Cowen and Lindquist 2005; Bennett et al. 2014; Berman 2016).”
BackgroundSelf-citationChromosome instability in Candida albicans
Rustchenko, E. (2007) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2006.00150.x · Cited by 116 · cited 3×
“A well-document mechanism by which FLC resistance is rapidly acquired in C. albicans is via aneuploidy (Perepnikhatka et al. 1999; Selmecki et al. 2006; Rustchenko 2007; Selmecki et al. 2010; Brimacombe et al. 2018).”
BackgroundTravisano, M., Vasi, F., & Lenski, R. E. (1995) · Evolution · doi:10.1111/j.1558-5646.1995.tb05970.x · Cited by 115 · cited 1×
“Cross-adaptation can be explained by pleiotropic side effects of adaptive mutations (Travisano et al. 1995; Velicer 1999; L az ar et al. 2014) or by hitchhiking of unselected mutations due to genetic linkage with an adaptive mutation (Guttman and Dykhuizen 1994).”
BackgroundHickman, M. A., Paulson, C., Dudley, A., & Berman, J. (2015) · Genetics · doi:10.1534/genetics.115.178020 · Cited by 113 · cited 1×
“Ploidy was analyzed using flow cytometry as described previously with some modifications (Hickman et al. 2015).”
MethodSelf-citationDr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer
Pavelka, N., Rancati, G., & Li, R. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.06.003 · Cited by 110 · cited 2×
“Because aneuploidy is associated with large and pleiotropic fitness effects across different environments (Pavelka et al. 2010), it raises the possibility that selection for aneuploidy of a particular chromosome in one environment could bias”
BackgroundSelf-citationTeoh, F., & Pavelka, N. (2016) · Pathogens · doi:10.3390/pathogens5010006 · Cited by 110 · cited 1×
“The increased risk of opportunistic infections is of particular concern for cancer patients undergoing chemotherapy, because of the immunosuppression that accompanies it (Teoh and Pavelka 2016).”
BackgroundSelf-citationBorst, A., Raimer, M. T., Warnock, D. W., Morrison, C. J., & Arthington-Skaggs, B. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.783-787.2005 · Cited by 106
Evidence for Hitchhiking of Deleterious Mutations within the Human Genome
Chun, S., & Fay, J. C. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002240 · Cited by 103
RECOMBINATION AND HITCHHIKING OF DELETERIOUS ALLELES: RECOMBINATION AND THE UNDESIRABLE HITCHHIKER
Hartfield, M., & Otto, S. P. (2011) · Evolution · doi:10.1111/j.1558-5646.2011.01311.x · Cited by 102
Lewis, J. S., Wiederhold, N. P., Wickes, B. L., Patterson, T. F., & Jorgensen, J. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01144-13 · Cited by 101
The Fitness Consequences of Aneuploidy Are Driven by Condition-Dependent Gene Effects
Sunshine, A. B., Payen, C., Ong, G. T., Liachko, I., Tan, K. M., & Dunham, M. J. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002155 · Cited by 99 · cited 6×
“albicans: wild and clinical isolates of the model yeast Saccharomyces cerevisiae often carry aneuploidies as well (Sunshine et al. 2015; Gallone et al. 2016; Gasch et al. 2016; Zhu et al. 2016; Peter et al. 2018).”
BackgroundInfluentialThe mammalian mycobiome: A complex system in a dynamic relationship with the host
Lai, G. C., Tan, T. G., & Pavelka, N. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1438 · Cited by 98 · cited 1×
“A leading cause of such infections is Candida albicans, a common member of the commensal microbiome (Brown et al. 2012; Mousset et al. 2014; Lai et al. 2019).”
BackgroundSelf-citationThe clinical use of mutagenic anticancer drugs
Ferguson, L. R., & Pearson, A. E. (1996) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(96)00019-x · Cited by 96
Aneuploid yeast strains exhibit defects in cell growth and passage through START
Thorburn, R. R., Gonzalez, C., Brar, G. A., Christen, S., Carlile, T. M., Ingolia, N. T., Sauer, U., Weissman, J. S., & Amon, A. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-07-0520 · Cited by 90 · cited 1×
“Aneuploidy often causes reduced fitness under some conditions (Thorburn et al. 2013) and thus we asked how exposure to HU (mimicking chemotherapy in the host) would affect the ability of C.”
BackgroundEvolution of the sex-Related Locus and Genomic Features Shared in Microsporidia and Fungi
Lee, S. C., Corradi, N., Doan, S., Dietrich, F. S., Keeling, P. J., & Heitman, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010539 · Cited by 87 · cited 1×
“chromosomes or chromosomal segments, arises at relatively high frequency in eukaryotic cells (Lee et al. 2010; Sterkers et al. 2012; Gallone et al. 2016; Gasch et al. 2016; Zhu et al. 2016).”
BackgroundPloidy plasticity: a rapid and reversible strategy for adaptation to stress
Berman, J. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fow020 · Cited by 83 · cited 1×
“Eukaryotic cells adapt to a broad range of stresses, with a classic example being the rapid adaptation of yeast cells to antifungal therapies (Cowen and Lindquist 2005; Bennett et al. 2014; Berman 2016).”
BackgroundSelf-citationYang, F., Zhang, L., Wakabayashi, H., Myers, J., Jiang, Y., Cao, Y., Jimenez-Ortigosa, C., Perlin, D. S., & Rustchenko, E. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00071-17 · Cited by 81 · cited 1×
““Next generation sequencing” was performed as described previously (Yang et al. 2017).”
MethodSelf-citationWhole chromosome aneuploidy: Big mutations drive adaptation by phenotypic leap
Chen, G., Rubinstein, B., & Li, R. (2012) · BioEssays · doi:10.1002/bies.201200069 · Cited by 79
Travisano, M., Vasi, F., & Lenski, R. E. (1995) · Evolution · doi:10.2307/2410304 · Cited by 72
Calcineurin Controls Hyphal Growth, Virulence, and Drug Tolerance of Candida tropicalis
Chen, Y.-L., Yu, S.-J., Huang, H.-Y., Chang, Y.-L., Lehman, V. N., Silao, F. G. S., Bigol, U. G., Bungay, A. A. C., Averette, A., & Heitman, J. (2014) · Eukaryotic Cell · doi:10.1128/ec.00302-13 · Cited by 68
Rapid Development of Candida krusei Echinocandin Resistance during Caspofungin Therapy
Forastiero, A., Garcia-Gil, V., Rivero-Menendez, O., Garcia-Rubio, R., Monteiro, M. C., Alastruey-Izquierdo, A., Jordan, R., Agorio, I., & Mellado, E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01005-15 · Cited by 68 · cited 1×
“glabrata, and Candida krusei (Pelletier et al. 2005; Baixench et al. 2007; Lewis et al. 2013; Forastiero et al. 2015; Sasso et al. 2017), as well as in Candida auris, which is intrinsically FLC-resistant and has caused multidrug-resistant A ricle”
BackgroundAbbey, D., Hickman, M., Gresham, D., & Berman, J. (2011) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.111.000885 · Cited by 64 · cited 2×
“Analysis of Type 1 and Type 2 survivors by flow cytometry (Abbey et al. 2011) revealed that the small colony Type 1 survivors had lower DNA content than the wild-type diploid control (fig.”
BackgroundMethodSelf-citationIndustrial Relevance of Chromosomal Copy Number Variation in Saccharomyces Yeasts
de Vries, A. R. G., Pronk, J. T., & Daran, J.-M. G. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.03206-16 · Cited by 62
Yang, F., Kravets, A., Bethlendy, G., Welle, S., & Rustchenko, E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00516-13 · Cited by 60 · cited 1×
“monosomy (Chr5x1) isolates that survive in CSP (Yang et al. 2013).”
BackgroundSelf-citationPelletier, R., Alarie, I., Lagacé, R., & Walsh, T. J. (2005) · Medical Mycology · doi:10.1080/13693780500220415 · Cited by 58 · cited 1×
“glabrata, and Candida krusei (Pelletier et al. 2005; Baixench et al. 2007; Lewis et al. 2013; Forastiero et al. 2015; Sasso et al. 2017), as well as in Candida auris, which is intrinsically FLC-resistant and has caused multidrug-resistant A ricle”
BackgroundRate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection
Shields, R. K., Nguyen, M. H., Press, E. G., Cumbie, R., Driscoll, E., Pasculle, A. W., & Clancy, C. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01973-15 · Cited by 55 · cited 1×
“Resistance to CSP is largely conferred by mutations within the “hot spot” regions of genes encoding beta-glucan synthase (Perlin 2015), however strains that do not carry these mutations and grow slowly in CSP are often isolated from patients (Castanheira et al. 2010; Shields et al. 2015).”
BackgroundHampe, I. A. I., Friedman, J., Edgerton, M., & Morschhäuser, J. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006655 · Cited by 52 · cited 1×
“In fact, experimental evolution of bacteria or yeast under one environmental condition sometimes leads to the acquisition of selective advantages in a second, unselected condition (Ferrari et al. 2009; Roux et al. 2015; Hampe et al. 2017).”
BackgroundGasch, A. P., Hose, J., Newton, M. A., Sardi, M., Yong, M., & Wang, Z. (2016) · eLife · doi:10.7554/elife.14409 · Cited by 47 · cited 2×
“chromosomes or chromosomal segments, arises at relatively high frequency in eukaryotic cells (Lee et al. 2010; Sterkers et al. 2012; Gallone et al. 2016; Gasch et al. 2016; Zhu et al. 2016).”
BackgroundAltamirano, S., Fang, D., Simmons, C., Sridhar, S., Wu, P., Sanyal, K., & Kozubowski, L. (2017) · mSphere · doi:10.1128/msphere.00205-17 · Cited by 46 · cited 1×
“More recently, the antifungal agent FLC was shown to induce abnormal mitoses and to increase the probability of tetraploidy and aneuploidy in several yeast species (Harrison et al. 2014; Altamirano et al. 2017).”
BackgroundKessi‐Pérez, E. I., Araos, S., García, V., Salinas, F., Abarca, V., Larrondo, L. F., Martínez, C., & Cubillos, F. A. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fow021 · Cited by 36
Pleiotropic Effects of Adaptation to a Single Carbon Source for Growth on Alternative Substrates
Velicer, G. J. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.1.264-269.1999 · Cited by 29
Trachtulcov�, P., Janatov�, I., Kohlwein, S. D., & ek, J. H. (2000) · Yeast · doi:10.1002/(sici)1097-0061(20000115)16:1 · Cited by 27
Brimacombe, C. A., Burke, J. E., Parsa, J.-Y., Catania, S., O’Meara, T. R., Witchley, J. N., Burrack, L. S., Madhani, H. D., & Noble, S. M. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000331 · Cited by 22
Rapid emergence of FKS mutations in Candida glabrata isolates in a peritoneal candidiasis
Sasso, M., Roger, C., & Lachaud, L. (2017) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2017.04.004 · Cited by 20 · cited 1×
“glabrata, and Candida krusei (Pelletier et al. 2005; Baixench et al. 2007; Lewis et al. 2013; Forastiero et al. 2015; Sasso et al. 2017), as well as in Candida auris, which is intrinsically FLC-resistant and has caused multidrug-resistant A ricle”
BackgroundChromatin rewiring mediates programmed evolvability via aneuploidyPreprint
Brimacombe, C. A., Burke, J. E., Parsa, J., Witchley, J. N., Burrack, L. S., Madhani, H. D., & Noble, S. M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/407841 · Cited by 3
Cited by
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Drug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642
Self-citationd'Enfert, C., Kaune, A.-K., Alaban, L.-R., Chakraborty, S., Cole, N., Delavy, M., Kosmala, D., Marsaux, B., Fróis-Martins, R., Morelli, M., et al. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa060 · Cited by 347
Molecular mechanisms governing antifungal drug resistance
Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304
“Recent work in C. albicans demonstrated that exposure to the cancer chemotherapeutic hydroxyurea, or the ER stress-inducing agent tunicamycin selects for trisomy of chromosome 2, which also enables tolerance to the echinocandin caspofungin 66,67 .”
Candida albicans biofilms and polymicrobial interactions
Ponde, N. O., Lortal, L., Ramage, G., Naglik, J. R., & Richardson, J. P. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1843400 · Cited by 281
“…including constitutive expression and activation of drug efflux pumps, mutation of genes encoding drug targets, the acquisition of drug tolerance (Berman and Krysan 2020), alterations in the copy number of genes via aneuploidy (Yang et al. 2019) and adaptive mistranslation (Weil et al. 2017).”
Background
Metadata
- Authors
- Yang, F., Teoh, F., Tan, A. S. M., Cao, Y., Pavelka, N., & Berman, J.
- Affiliations
- Tel Aviv University (IL)
- Agency for Science, Technology and Research (SG)
- Shanghai University of Traditional Chinese Medicine (CN)
- Corresponding author
- Pavelka, Norman
- Berman, Judith
- Venue
- Molecular Biology and Evolution
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-04-27
- Volume
- 36
- Issue
- 8
- Pages
- 1768-1782
- ISSN
- 0737-4038 (ISSN-L)
- 1537-1719
- PMC
- PMC6657732
- OpenAlex
- W2940793950
- Cited by
- 101
- References
- 91
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 13 · 2023: 15 · 2022: 15 · 2021: 17 · 2020: 13 · 2019: 6
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Biology and Evolution (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Research Council (340087)
- Agency for Science, Technology and Research (JCO/1437a00117)
- Singapore Immunology Network
- National Science Foundation of China (81872910)
- A*STAR Graduate Scholarship
- PBC China-Israel Postdoctoral Fellowship Program
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- aneuploidy, cross-adaptation, Candida albicans, drug tolerance, antifungal resistance, chemoresistance, hydroxyurea, caspofungin, fluconazole, trisomy, monosomy, chromosome 2, chromosome 5, stress response pathways, systemic candidiasis, fungal pathogens
- MeSH terms
- Caspofungin, Adaptation, Biological, Aneuploidy, Animals, Antifungal Agents, Antineoplastic Agents, Candida albicans, Hydroxyurea, Chromosomes, Fungal, Calcineurin, Drug Resistance, Fungal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.